Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical Investigation
J Clin Invest. 2013 August 1; 123(8): 3404–3408.
Published online 2013 July 15. doi:  10.1172/JCI67803
PMCID: PMC3726164

Recruited brown adipose tissue as an antiobesity agent in humans


Brown adipose tissue (BAT) burns fat to produce heat when the body is exposed to cold and plays a role in energy metabolism. Using fluorodeoxyglucose-positron emission tomography and computed tomography, we previously reported that BAT decreases with age and thereby accelerates age-related accumulation of body fat in humans. Thus, the recruitment of BAT may be effective for body fat reduction. In this study, we examined the effects of repeated stimulation by cold and capsinoids (nonpungent capsaicin analogs) in healthy human subjects with low BAT activity. Acute cold exposure at 19°C for 2 hours increased energy expenditure (EE). Cold-induced increments of EE (CIT) strongly correlated with BAT activity independently of age and fat-free mass. Daily 2-hour cold exposure at 17°C for 6 weeks resulted in a parallel increase in BAT activity and CIT and a concomitant decrease in body fat mass. Changes in BAT activity and body fat mass were negatively correlated. Similarly, daily ingestion of capsinoids for 6 weeks increased CIT. These results demonstrate that human BAT can be recruited even in individuals with decreased BAT activity, thereby contributing to body fat reduction.


Brown adipose tissue (BAT), a site of nonshivering thermogenesis, shows promise in combating obesity, since it contributes to the regulation of whole-body energy expenditure (EE) and body fat content in small rodents (1). Recent studies using fluorodeoxyglucose-PET (FDG-PET) in combination with CT revealed that adult humans have considerable amounts of BAT (25). The prevalence and activity of human BAT, as assessed by FDG-PET/CT, are inversely related to body fat content and decrease with age (24). We previously reported that the body fat content of subjects with undetectable activities of BAT increased with age, while those of subjects with detectable activities of BAT remained unchanged from 20s to 40s (6), which suggests that the age-related decrease in BAT activity accelerates the accumulation of body fat. It is therefore expected that the reactivation and/or recruitment of BAT may protect against the onset of obesity and related metabolic disorders in humans. Vijgen et al. (7) reported increased BAT activity after weight loss in obese patients given gastric banding surgery, suggesting the effectiveness of successful recruitment of BAT in body fat reduction in humans.

Cold exposure is the most powerful and physiological stimulus for BAT activation, both in small rodents and in humans (2, 811). It is known that the stimulatory effects of cold on BAT are mediated through the activation of the sympathetic nervous system, initiated by peripheral stimulation of transient receptor potential (TRP) channels in sensory neurons (8, 12). This pathway is also activated by some food ingredients, such as capsaicin and capsinoids, nonpungent capsaicin analogs (13, 14). Stimulation of TRP channels by capsinoids is effective for enhancement of BAT thermogenesis and upregulation of uncoupling protein 1 (UCP1), a key molecule of BAT thermogenesis, in mice (14).

The present study explored how to reactivate and recruit human BAT by examining the effects of chronic stimulation by cold and capsinoids on BAT in healthy adults with low or undetectable activities of BAT. Our results showed that human BAT could be recruited even in individuals who had lost BAT, thereby contributing to body fat reduction. This is the first report of successful recruitment of BAT leading to reduced body fat in humans.

Results and Discussion

Acute effects of cold exposure on BAT thermogenesis.

The metabolic activity of human BAT, as assessed by FDG-PET/CT, is undetectably low in warm conditions, but increases within hours after cold exposure (2). To examine the acute effects of cold on BAT in detail, we recruited 51 healthy young male subjects, in order to minimize any possible effects of age and sex on BAT activity (2, 4). First, the subjects underwent FDG-PET/CT after 2-hour cold exposure at 19°C to assess BAT activity. Of the 51, 27 subjects (52.9%) showed cold-activated BAT (BAT-positive subjects; Figure Figure1A),1A), and 24 did not (BAT-negative subjects; Figure Figure1B).1B). This was closely consistent with our previous results showing that cold-activated BAT could be detected in approximately 50% of young subjects (2, 6, 9). There was no significant difference between the BAT-positive and -negative subjects with respect to age, body weight, body fat mass, or fat-free mass (Figure (Figure1E).1E). BAT activity, assessed by FDG uptake into supraclavicular fat depots, was significantly higher in BAT-positive than BAT-negative subjects (5.5 ± 0.6 vs. 1.2 ± 0.1 standardized uptake value [SUV], P < 0.0001; Figure Figure11I).

Figure 1
Contribution of BAT to whole-body EE.

To quantify the contribution of BAT to whole-body EE in humans, we measured whole-body EE under warm conditions at 27°C and after 2-hour cold exposure at 19°C using a respiratory gas analyzer (Supplemental Figure 1; supplemental material available online with this article; doi: 10.1172/JCI67803DS1). EE at 27°C was almost the same between BAT-positive and -negative subjects (Figure (Figure1C).1C). After 2-hour cold exposure, EE increased significantly in both BAT-positive and -negative subjects. Cold-induced thermogenesis (CIT), calculated as the difference between EE values at 27°C and 19°C, was significantly higher in BAT-positive than BAT-negative subjects (252.0 ± 41.1 vs. 78.4 ± 23.8 kcal/d, P < 0.01; Figure Figure1D).1D). It is known that body composition, especially fat-free mass, is a significant determinant of EE (15). We therefore analyzed the associations of fat-free mass and BAT activity with EE using regression analyses. Fat-free mass closely related to EE at 27°C and 19°C, but not to CIT (Figure (Figure1,1, F–H). BAT activity was significantly related to EE at 19°C and to CIT, but not to EE at 27°C (Figure (Figure1,1, J–L). Multivariate regression models revealed independent associations of BAT activity with EE at 19°C and with CIT (P < 0.001 and P < 0.0001, respectively; Supplemental Table 1).

The metabolically active component of fat-free mass is mainly skeletal muscle (15). It is also known that shivering by skeletal muscle becomes one of the dominant components of EE in severe cold conditions, such as at 5°C–10°C (16). Orava et al. (10) reported that increased FDG uptake after cold exposure at 17°C was evident in BAT, but negligible in other tissues, including skeletal muscle. This implies that muscle shivering in the present study at 19°C may be negligible. In fact, we found no significant correlation between fat-free mass and CIT. These results demonstrated that BAT activity becomes a dominant component of CIT at 19°C, independent of fat-free mass (Figure (Figure1L),1L), which indicates that CIT at 19°C is an index of BAT activity.

Chronic effects of cold exposure on BAT activity/thermogenesis and body fat.

In small rodents, prolonged cold exposure induces BAT hyperplasia (1). To examine whether this is also the case in humans, 22 subjects with low or undetectable activities of BAT were randomly assigned to 2 groups: one was exposed to cold at 17°C for 2 hours every day (cold group; n = 12), while the other maintained their normal lifestyles without any exposure (control group; n = 10) (Supplemental Figure 1). Before and after a 6-week period, EE, body composition, and BAT activity were measured.

Detectable activities of BAT were found in 3 of 8 subjects at week 0 (subjects 3, 6, and 7) and in 6 subjects at week 6 (subjects 1, 2, 3, 6, 7, and 8; Figure Figure2A).2A). BAT activity increased after the 6-week cold exposure from 2.46 ± 0.40 to 3.89 ± 0.64 SUV (P = 0.001; Figure Figure2B).2B). Importantly, individuals with undetectable activities of BAT at week 0 (subjects 1, 2, and 8) showed active BAT at week 6. In small rodents, chronic cold exposure results in induction of UCP1, hyperplasia of BAT, and a concomitant increase in 2-deoxy-d-glucose (2-DG) uptake into BAT (1). Moreover, we previously demonstrated in mice that 2-DG uptake into BAT is largely dependent on the presence of UCP1 (17). Thus, it is quite likely that the increased BAT activity (assessed by FDG uptake) is attributable to recruitment of BAT and/or induction of UCP1. This is compatible with a report by Lee et al., who demonstrated higher UCP1 expression in human subjects with higher BAT activities, as assessed by FDG-PET/CT (18).

Figure 2
BAT recruitment by chronic cold exposure.

EE at 27°C did not change during the 6-week period in both the cold group and the control group. However, EE after 2-hour cold exposure of the cold group significantly increased after 6 weeks, whereas it did not change in the control group (Supplemental Figure 2A). In fact, CIT of the cold group at week 6 (289.0 ± 70.0 kcal/d) was significantly higher than the cold group at week 0 (108.4 ± 22.8 kcal/d, P < 0.05) and the control group at week 6 (108.2 ± 31.1 kcal/d, P < 0.05; Figure Figure3D).3D). The change in CIT during the 6-week period for the cold group was significantly higher than that for the control group (180.6 ± 69.5 vs. 5.0 ± 39.5 kcal/d, P < 0.05), and positively correlated to the change in BAT activity (r = 0.43, P < 0.05; Figure Figure3G).3G). These results, together with the highly positive correlation between CIT and BAT activity (Figure (Figure1L),1L), indicate that recruited BAT actually contributes to CIT.

Figure 3
Effects of chronic stimulation by cold and capsinoids.

Body fat mass of the cold group significantly decreased at week 6 compared with week 0 (–5.2% ± 1.9% change, P < 0.05), whereas body weight and fat-free mass did not change significantly (Figure (Figure3A).3A). In contrast, in the control group, there was no significant change in these parameters. During the 6-week period, body fat mass decreased more in the cold group than in the control group (–0.70 ± 0.23 vs. 0.03 ± 0.21 kg, P < 0.05; Figure Figure3C).3C). The change in body fat mass was inversely correlated with that in BAT activity (r = –0.62, P < 0.01; Figure Figure3F)3F) and insignificantly with that in CIT (r = –0.43, P = 0.08; Figure Figure3H),3H), which suggests that increased BAT leads to body fat reduction.

Chronic effects of capsinoids on BAT activity/thermogenesis and body fat.

Although our results are the first demonstration of the effective recruitment of human BAT, it would seem difficult to increase exposure to cold in daily life. To explore more practical methods for the recruitment of BAT, we focused on the chemical stimulants of TRP channels, particularly capsinoids. Because capsinoids activate TRPV1 and TRPA1 (13) and increase BAT thermogenesis (14, 19), we reasoned that long-term capsinoid treatment could possibly recruit BAT in humans, as chronic cold exposure does.

To test this idea, we selected 10 subjects with low or undetectable activities of BAT and examined the effects of daily ingestion of capsinoids on BAT (Supplemental Figure 1). In this experiment, we measured CIT before and 6 weeks after ingestion as a predictive index of BAT activity, instead of repeated FDG-PET/CT. Resting EE at 27°C was almost the same before and after treatment with capsinoids or a placebo. A significant increase in EE by 2-hour cold exposure was found only after capsinoid treatment (Supplemental Figure 2B). CIT after capsinoid treatment (200.0 ± 33.9 kcal/d) was higher than that before capsinoid treatment (20.6 ± 43.0 kcal/d, P < 0.01) and after placebo treatment (81.0 ± 32.5 kcal/d, P < 0.01; Figure Figure3E).3E). As CIT was proportional to BAT activity, as assessed by FDG-PET/CT, the capsinoid-induced increase in CIT appears to reflect enhanced thermogenic capacity and BAT activity.

Ono et al. reported that prolonged treatment of rats with capsinoids resulted in increased UCP1 expression and decreased body fat (14). Body fat reduction and increased EE were also shown after capsinoid treatment for 12 weeks in mildly obese human subjects (20). In the present study in nonobese subjects, the 6-week capsinoid treatment increased EE, although it caused only a slight and insignificant reduction of body fat (2% reduction; Figure Figure3B).3B). All these results suggest that the antiobesity effects of capsinoids are based on the thermogenic activity of recruited BAT. Thus, repeated ingestion of capsinoids can mimic the chronic effects of cold exposure on BAT and body fat in humans.

Is BAT recruited by cold and capsinoids composed of brown adipocytes or beige cells?

Current evidence suggests that rodents possess 2 types of UCP1-positive adipocytes arising from distinct developmental lineages: “classical brown adipocytes,” derived from Myf5-positive myoblastic cells, and “beige cells,” which reside in white adipose tissue and are induced in response to some environmental cues, such as cold exposure and β3-adrenergic receptor agonists (21). BAT in the supraclavicular region of human subjects was reported to be mainly composed of beige cells (22, 23). Lee et al. also demonstrated that preadipocytes isolated from supraclavicular fat of subjects with undetectable BAT have the ability to differentiate into UCP1-expressing adipocytes in vitro (24). It therefore appears likely that the BAT recruited by cold and capsinoids in our present study is composed of beige cells.

In conclusion, we demonstrated here that human BAT can be recruited by chronic cold exposure and capsinoid ingestion even in individuals who have lost active BAT. Our findings could contribute to developing practical, easy, and effective antiobesity regimens.


Further information can be found in Supplemental Methods.


51 healthy male volunteers (age, 24.4 ± 0.5 years; BMI, 22.0 ± 0.4 kg/m2; body fat mass, 11.7 ± 0.7 kg; fat-free mass, 54.0 ± 0.7 kg) participated in the present study.


All subjects underwent FDG-PET/CT after 2-hour cold exposure at 19°C in winter as described previously (2, 6, 9, 19).

Indirect calorimetry.

EE was measured using a respiratory gas analyzer at 27°C and after 2-hour cold exposure at 19°C as described previously (6).

Repeated cold exposure.

22 subjects showing low or undetectable activities of BAT were randomly divided into 2 groups: one was exposed to cold at 17°C for 2 hours every day for 6 weeks (cold group; n = 12); the other maintained their usual lifestyles without cold exposure during the same period (control group; n = 10). Body fat content and EE at 27°C and after 2-hour cold exposure at 19°C were measured before and after the 6-week period (Supplemental Figure 1). 8 of the 12 subjects of the cold group underwent FDG-PET/CT examination again after 6-week cold exposure.

Daily ingestion of capsinoids.

Capsinoids were extracted from CH-19 Sweet (Capsicum annuum L.), purified, and encapsulated (19). 10 subjects with low or undetectable activities of BAT participated in this randomized, single-blinded, placebo-controlled crossover trial. They ingested the capsules containing 9 or 0 mg (placebo) capsinoids every day for 6 weeks. Before and after the 6-week period, body fat content and EE at 27°C and after 2-hour cold exposure at 19°C were measured (Supplemental Figure 1).


Data are expressed as mean ± SEM. Comparisons between groups were analyzed using t test or nonparametric test; 2-sided P values are given. Correlations were assessed using univariate and multivariate regressions. A P value less than 0.05 was considered statistically significant.

Study approval.

The protocols were approved by the Institutional Research Ethics Review Board of Tenshi College (Sapporo, Japan). The trials were registered at (trial IDs UMIN000009005 and UMIN000006810). All participants were carefully instructed regarding the study and gave their informed consent.

Supplementary Material

Supplemental data:


This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grant no. 22590227).


Conflict of interest: The authors have declared that no conflict of interest exists.

Citation for this article: J Clin Invest. 2013;123(8):3404–3408. doi:10.1172/JCI67803.


1. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84(1):277–359. doi: 10.1152/physrev.00015.2003. [PubMed] [Cross Ref]
2. Saito M, et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes. 2009;58(7):1526–1531. doi: 10.2337/db09-0530. [PMC free article] [PubMed] [Cross Ref]
3. van Lichtenbelt WDM, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009;360(15):1500–1508. doi: 10.1056/NEJMoa0808718. [PubMed] [Cross Ref]
4. Cypess AM, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360(15):1509–1517. doi: 10.1056/NEJMoa0810780. [PMC free article] [PubMed] [Cross Ref]
5. Virtanen KA, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360(15):1518–1525. doi: 10.1056/NEJMoa0808949. [PubMed] [Cross Ref]
6. Yoneshiro T, et al. Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans. Obesity. 2011;19(9):1755–1760. doi: 10.1038/oby.2011.125. [PubMed] [Cross Ref]
7. Vijgen GH, et al. Increase in brown adipose tissue activity after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2012;97(7):E1229–E1233. doi: 10.1210/jc.2012-1289. [PubMed] [Cross Ref]
8. Nakamura K. Central circuitries for body temperature regulation and fever. Am J Physiol Regul Integr Comp Physiol. 2011;301(5):R1207–R1228. doi: 10.1152/ajpregu.00109.2011. [PubMed] [Cross Ref]
9. Yoneshiro T, et al. Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men. Obesity. 2011;19(1):13–16. doi: 10.1038/oby.2010.105. [PubMed] [Cross Ref]
10. Orava J, et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab. 2011;14(2):272–279. doi: 10.1016/j.cmet.2011.06.012. [PubMed] [Cross Ref]
11. Ouellet V, et al. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest. 2012;122(2):545–552. doi: 10.1172/JCI60433. [PMC free article] [PubMed] [Cross Ref]
12. Tajino K, Hosokawa H, Maegawa S, Matsumura K, Dhaka A, Kobayashi S. Cooling-sensitive TRPM8 is thermostat of skin temperature against cooling. PLoS One. 2011;6(3):e17504. doi: 10.1371/journal.pone.0017504. [PMC free article] [PubMed] [Cross Ref]
13. Shintaku K, et al. Activation of transient receptor potential A1 by a non-pungent capsaicin-like compound, capsiate. Br J Pharmacol. 2011;165(5):1476–1486. doi: 10.1111/j.1476-5381.2011.01634.x. [PMC free article] [PubMed] [Cross Ref]
14. Ono K, et al. Intragastric administration of capsiate, a transient receptor potential channel agonist, triggers thermogenic sympathetic responses. J Appl Physiol. 2011;110(3):789–798. doi: 10.1152/japplphysiol.00128.2010. [PubMed] [Cross Ref]
15. Müller MJ, Bosy-Westphal A, Kutzner D, Heller M. Metabolically active components of fat-free mass and resting energy expenditure in humans: recent lessons from imaging technologies. Obes Rev. 2002;3(2):113–122. doi: 10.1046/j.1467-789X.2002.00057.x. [PubMed] [Cross Ref]
16. Haman F, Péronnet F, Kenny GP, Massicotte D, Lavoie C, Weber JM. Partitioning oxidative fuels during cold exposure in humans: muscle glycogen becomes dominant as shivering intensifies. J Physiol. 2005;566(pt 1):247–256. doi: 10.1113/jphysiol.2005.086272. [PubMed] [Cross Ref]
17. Inokuma K, Ogura-Okamatsu Y, Toda C, Kimura K, Yamashita H, Saito M. Uncoupling protein 1 is necessary for norepinephrine-induced glucose utilization in brown adipose tissue. Diabetes. 2005;54(5):1385–1391. doi: 10.2337/diabetes.54.5.1385. [PubMed] [Cross Ref]
18. Lee P, et al. High prevalence of brown adipose tissue in adult humans. J Clin Endocrinol Metab. 2011;96(8):2450–2455. doi: 10.1210/jc.2011-0487. [PubMed] [Cross Ref]
19. Yoneshiro T, Aita S, Kawai Y, Iwanaga T, Saito M. Nonpungent capsaicin analogs (capsinoids) increase energy expenditure through the activation of brown adipose tissue in humans. Am J Clin Nutr. 2012;95(4):845–850. doi: 10.3945/ajcn.111.018606. [PubMed] [Cross Ref]
20. Snitker S, et al. Effects of novel capsinoid treatment on fatness and energy metabolism in humans: possible pharmacogenetic implications. Am J Clin Nutr. 2009;89(1):45–50. doi: 10.3945/ajcn.2008.26561. [PubMed] [Cross Ref]
21. Ishibashi J, Seale P. Medicine. Beige can be slimming. Science. . 2010;328(5982):1113–1114. doi: 10.1126/science.1190816. [PMC free article] [PubMed] [Cross Ref]
22. Wu J, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012;150(2):366–376. doi: 10.1016/j.cell.2012.05.016. [PMC free article] [PubMed] [Cross Ref]
23. Sharp LZ, et al. Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS One. 2012;7(11):e49452. doi: 10.1371/journal.pone.0049452. [PMC free article] [PubMed] [Cross Ref]
24. Lee P, Swarbrick MM, Zhao JT, Ho KK. Inducible brown adipogenesis of supraclavicular fat in adult humans. Endocrinology. 2011;152(10):3597–3602. doi: 10.1210/en.2011-1349. [PubMed] [Cross Ref]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation